Ldh Assay

The assay couples LDH activity to the reversible reaction between pyruvate, lactate, NADH, and NAD+. As LDH catalyzes conversion of pyruvate to lactate, NADH is converted to NAD+. The resulting change in NADH absorbance at 340 nm provides a measurable signal that reflects enzyme activity in the biological sample.

NADH provides the optical readout for the enzymatic reaction. Its conversion to NAD+ changes absorbance, and monitoring that change at 340 nm allows the reaction to be quantified. This links the spectroscopic measurement to LDH activity rather than relying only on the presence or absence of the enzyme.

LDH release indicates that cellular or tissue integrity has been compromised enough for the enzyme to enter the surrounding biological sample. Consequently, measured activity can serve as an indicator of cellular injury or tissue damage. In cell-based experiments, the same principle is used to evaluate membrane damage and cytotoxicity.

An enzymatic format focuses on the reaction catalyzed by LDH and quantifies the associated NADH absorbance change. A cell-based format instead uses LDH released from cells as an indicator of membrane damage or cytotoxicity. Thus, the formats share the same enzyme-related signal but answer different experimental questions about activity versus cell injury.

A typical workflow obtains a biological sample or a cell-based experimental sample, exposes the sample to the LDH reaction system, and monitors the resulting NADH absorbance change at 340 nm. The measured signal is then interpreted as enzyme activity or as evidence of cellular membrane damage, depending on the assay format.

In medicine, LDH assay results can support evaluation of hemolysis, liver injury, and muscle injury. They may also help follow disease progression or assess treatment response. The test therefore contributes to monitoring tissue damage over time, while the specific interpretation depends on the clinical context and the type of biological sample analyzed.

Cell-based LDH assays are useful when researchers need an experimental readout of membrane damage or cytotoxicity. Measuring enzyme released from damaged cells can help evaluate how an experimental condition affects cell integrity. This application extends the assay beyond clinical assessment and supports studies focused on cellular injury and responses to treatment.

Repeated LDH measurements can help track changes associated with disease progression or treatment response. A changing enzyme signal may indicate that the extent of cellular or tissue injury is changing over time. In this context, the assay functions as a monitoring tool, complementing its use for evaluating hemolysis, liver injury, or muscle injury.